Stanford Bio-X affiliated faculty members and fellows are generating scientific advances that expand our understanding of how the body works and will ultimately improve human health. These news stories and press releases describe some of those breakthroughs.
October 12, 2018 - Stanford News
A new computer model from Stanford Bio-X affiliated faculty member Ellen Kuhl maps how misshapen proteins associated with Alzheimer’s and Parkinson’s diseases and ALS spread throughout the brain. The work, supported by a Stanford Bio-X IIP Seed Grant, could aid in finding ways to diagnose and treat these neurodegenerative disorders.
March 8, 2017 - Stanford Medicine News Center
Bio-X affiliate Michael Greicius found that teaching ordinary people a technique used by “memory athletes” not only boosted their recall ability but also induced lasting changes in the organization of their brains.
March 7, 2017
Among philanthropist William Bowes’s many contributions to science are hundreds of interdisciplinary graduate students he supported through Bio-X Bowes Fellowships. He passed away in December 2016.
March 6, 2017 - Stanford Medicine News Center
Bio-X affiliate Polly Fordyce uses microfluidic tools to understand protein interactions in the body — knowledge that could help researchers develop therapeutics for a variety of diseases. She collaborates with Bio-X affiliated faculty members Matthew Bogyo and Martha Cyert, and the latter collaboration is supported by a Stanford Bio-X IIP Seed Grant.
March 2, 2017 - Stanford Medicine Scope
Bio-X affiliate Michael Eisenberg is conducting the Stanford CYCling and Lower Effects (CYCLE) study to hone in on the factors affecting the comfort and safety of cycling.
February 22, 2017 - Stanford News
Impulsive behavior in teens can go hand in hand with drug use, but the link is weak and doesn’t necessarily predict future behavior. Bio-X affiliate Brian Knutson and colleagues think they can do better, using images of the brain.
February 22, 2017 - Stanford News
Bio-X affiliate Michael Frank and other researchers used a novel statistical approach to analyze children’s early speech and found evidence that toddlers develop knowledge of grammar with time and practice.
February 27, 2017 - Stanford Medicine News Center
To develop a potential antiviral treatment, Bio-X affiliates Shirit Einav and Claude Nagamine, with support from a Bio-X IIP Seed Grant, adopted an unusual approach: they targeted proteins the infected individual makes, and the virus needs.
February 21, 2017 - Stanford Medicine News Center
In work by Bio-X affiliates Krishna Shenoy, Jaime Henderson, and Paul Nuyujukian, supported by the Bio-X NeuroVentures Program, three participants with movement impairment controlled an onscreen cursor by imagining hand movements.
February 21, 2017 - Stanford Medicine News Center
Bio-X affiliates Krishna Shenoy and Jaime Henderson have worked together to develop an experimental technology that could one day allow people with paralysis to affect the world around them using only their minds.
February 20, 2017 - Stanford News
Supported by a Bio-X IIP Seed Grant, Bio-X affiliates Nicholas Melosh, Joseph Wu, and Sergiu Pasca work on tiny nanostraws that sample cells' contents without damaging them, which could help us understand cell processes and improve medical treatments.
February 17, 2017 - Stanford News
A new way of extracting uranium from seawater described by Bio-X affiliates Yi Cui and Steven Chu could help even countries without uranium mines harness nuclear power.
February 16, 2017 - Stanford Medicine News Center
Alpha cells can convert to insulin-producing beta cells in mice when just two genes are blocked, a new Stanford study from Bio-X affiliates Seung Kim and Stephen Quake shows. A similar mechanism may occur in people with diabetes.
February 16, 2017 - Stanford News
A collaboration under Bio-X affiliates Robert Waymouth, Paul Wender, and Chris Contag produced a new way of inserting the code for modified proteins into the cells of mice. If successful in humans, this could be useful for vaccines or cancer therapies.
February 15, 2017 - Stanford Medicine News Center
Stanford researchers under Bio-X affiliates Joseph Wu, Alice Fan, and Sean Wu have developed a test that may help screen for cardiotoxicity in new chemotherapy drugs.
February 15, 2017 - Stanford Medicine News Center
Bio-X affiliate Jason Andrews and his colleagues found that a screening test for tuberculosis was a good predictor of whether children infected with the bacteria would become sick.
February 14, 2017 - Stanford Medicine News Center
Heart patients with implantable cardioverter defibrillators often undergo a series of health care procedures when they receive shocks from the devices, regardless of whether the shocks are necessary, Bio-X affiliate Mintu Turakhia says.
February 13, 2017 - Stanford Medicine Scope
Researchers under Bio-X affiliates Gregory Scherrer, Karl Deisseroth, Scott Delp, Robert Malenka, and Liqun Luo identify a neural circuit in the brain that helps explain how the body uses enkephalins, which have potent painkilling properties.
February 13, 2017 - Stanford News
Researchers under Bio-X affiliate Gordon Wetzstein are developing a type of virtual reality display that adapts to differences in how we see, which could reduce headaches or nausea caused by existing VR headsets.
February 10, 2017 - Stanford Medicine Scope
Researchers under Bio-X affiliate Gregory Barsh found that a gene that normally causes pale belly fur has been co-opted to help create a pattern of light and dark stripes on the backs of both striped mice and on distantly-related chipmunks.
February 9, 2017 - Stanford News
The world is changing too fast for nature to keep up. Conservation scholars including Bio-X affiliate Elizabeth Hadly agree that strategies need to consider not only how ecosystems operated in recent years, but also thousands and millions of years ago.
February 8, 2017 - Stanford Medicine Scope
Bio-X affiliate Denise Monack and her colleagues have figured out how ST313, a mutant strain of Salmonella, spreads beyond the gut.
February 7, 2017 - Stanford News
A new low-cost, high-performance battery developed under Bio-X affiliate Hongjie Dai could provide an inexpensive storage solution for solar power, which is abundant during the day but must be stored for use at night.
February 6, 2017 - Stanford Medicine News Center
Microfluidics, electronics and inkjet technology underlie a newly developed all-in-one biochip from Bio-X affiliates Ron Davis and James Harris that can analyze cells for research and clinical applications.
February 6, 2017 - Stanford News
With three methods of research, Bio-X affiliates Jure Leskovec and Michael Bernstein find that the situation in which an online discussion occurs influences whether people will troll more than their personal past of trolling suggests.
February 2, 2017 - Stanford Medicine Scope
Bio-X affiliate Stephen Luby has been tapped to direct the health evaluation of a project to use water management strategies to potentially improve the lives of more than a billion people globally.
January 31, 2017 - Stanford Engineering
Bio-X affiliate Alison Marsden explains that computer based simulations would enable physicians to test different treatment options and provide a way to choose the best strategy for each patient.
January 26, 2017 - Stanford News
The new technique, from Bio-X affiliate Jin Hyung Lee and Bio-X Fellow Andrew Weitz, probes the neural pathways that cause Parkinson's disease tremors, and also provides a way to map and troubleshoot other circuits in the whole brain.
January 25, 2017 - Stanford News
In hopes of creating better access to medical care, Stanford researchers under Bio-X affiliate Helen Blau have trained an algorithm to diagnose skin cancer.
January 25, 2017 - Stanford Medicine News Center
Growing organs from one species in another may one day relieve transplant shortages. Researchers under Bio-X affiliate Hiromitsu Nakauchi show that islets from rat-grown mouse pancreases can reverse disease when transplanted into diabetic mice.
January 24, 2017 - Stanford Medicine Scope
Bio-X affiliates Connie Weyand and Jorg Goronzy have discovered that in giant cell arteritis, in which the immune system attacks the aorta, the immune response is too strong because an immune checkpoint isn’t braking hard enough.
James H. Clark Center, Stanford University 318 Campus Drive Stanford, CA 94305 Phone: 650.724.3333
© Stanford University, Stanford, California 94305
